In contrast, no such decline was apparent in his brother, referred to as brother B. Brother A showed typical biomarker signs of Alzheimer’s disease, starting with an early decrease in CSF amyloid-β42 and later progressing to an increase in CSF T-tau and P-tau. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.